Amy N. Luckenbaugh

About

Amy N. Luckenbaugh is a urologic oncologist whose research advances surgical precision and patient safety in genitourinary cancer care. Her work spans robotic-assisted surgeries for testicular, prostate, and bladder cancers, with a focus on optimizing oncologic outcomes while minimizing complications. She led a landmark study on primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer (115 citations), demonstrating its safety and early oncologic effectiveness. Dr. Luckenbaugh also pioneered techniques to prevent incisional hernias after robotic prostatectomy and contributed to synthesizing evidence comparing robotic versus open cystectomy for bladder cancer. Her innovative use of near-infrared autofluorescence for label-free adrenal gland visualization during surgery represents a significant advance in intraoperative guidance. Additionally, she has authored work on collaborative quality initiatives, reflecting her commitment to systematic improvement in surgical care. Through these contributions, Dr. Luckenbaugh is shaping the future of minimally invasive urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer

   115 citations · 2016
2. 2
   The prevention of extraction site incisional hernia after robotic-assisted radical prostatectomy

   11 citations · 2021
3. 3
   Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses

   9 citations · 2023
4. 4
   Label‐Free Enhancement of Adrenal Gland Visualization Using Near‐Infrared Autofluorescence for Surgical Guidance

   7 citations · 2022
5. 5
   Collaborative Quality Initiatives

   3 citations · 2018

Key Collaborators

Contact & Links